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Abstract
BICD2 is one of the two mammalian homologues of the Drosophila Bicaudal D, an evolutionarily conserved adaptor
between microtubule motors and their cargo that was previously shown to link vesicles and mRNP complexes to the dynein
motor. Here, we identified a G2-specific role for BICD2 in the relative positioning of the nucleus and centrosomes in dividing
cells. By combining mass spectrometry, biochemical and cell biological approaches, we show that the nuclear pore complex
(NPC) component RanBP2 directly binds to BICD2 and recruits it to NPCs specifically in G2 phase of the cell cycle. BICD2, in
turn, recruits dynein-dynactin to NPCs and as such is needed to keep centrosomes closely tethered to the nucleus prior to
mitotic entry. When dynein function is suppressed by RNA interference-mediated depletion or antibody microinjection,
centrosomes and nuclei are actively pushed apart in late G2 and we show that this is due to the action of kinesin-1.
Surprisingly, depletion of BICD2 inhibits both dynein and kinesin-1-dependent movements of the nucleus and cytoplasmic
NPCs, demonstrating that BICD2 is needed not only for the dynein function at the nuclear pores but also for the
antagonistic activity of kinesin-1. Our study demonstrates that the nucleus is subject to opposing activities of dynein and
kinesin-1 motors and that BICD2 contributes to nuclear and centrosomal positioning prior to mitotic entry through
regulation of both dynein and kinesin-1.
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Introduction
Spatial organization of eukaryotic cells requires active transport
of proteins, macromolecular assemblies, and membrane organelles
along cytoskeletal fibers. Transport is driven by motor proteins,
which use actin and microtubules (MTs) as tracks for their
movement. Cytoskeletal elements are polarized structures, and
each particular motor can move along them only in one direction.
For example, MT-based motors include kinesins, which with a few
exceptions walk to MT plus ends, and dyneins, which drive minus
end-directed transport [1].
Motor-dependent transport machineries display a high degree
of complexity. First, the same motor can move multiple cargos.
For example, cytoplasmic dynein is responsible for the movement
of the majority of membrane organelles, mRNAs, and proteins to
MT minus ends [1,2]. Second, the same cargo can simultaneously
associate with multiple motors of opposite polarity and frequently
switch the direction of movement [3,4]. Molecular mechanisms
responsible for motor recruitment, activation, and switching of
directions are still poorly understood. Motors are likely to be
controlled by cargo-specific adaptor complexes, which often
include structural components and small GTPases [5,6].
An example of a well-studied motor adaptor is Bicaudal D
(BICD), which is conserved throughout the animal kingdom [7].
BICD consists of several coiled coil segments separated by regions
expected to be highly flexible. The N-terminal part of BICD binds
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to cytoplasmic dynein and its accessory factor dynactin; moreover,
the BICD N-terminus is sufficient to recruit these complexes to
organelles [8,9]. The C-terminal domain of BICD is the cargo-
binding part of the molecule. In mammals and flies, it directly
associates with the small GTPase Rab6 [10–12]. In mammalian
cells, BICD participates in recruitment of dynein/dynactin to
Rab6-positive exocytotic vesicles and promotes their MT minus
end-directed transport [11,13]. The middle portion of BICD
weakly binds to kinesin-1 [13]. The functional role of this link is
not yet clear, but it is noteworthy that BICD-bound Rab6 vesicles
move mostly towards the MT plus ends, suggesting that kinesin
motor activity on Rab6 vesicles predominates over dynein-
dependent transport [11,13]. In Drosophila, BicD participates in
dynein-dependent mRNP transport [14,15]. This function de-
pends on the association of BicD C terminus with the RNA-
binding protein Egalitarian [15–17]. BicD is also involved in both
dynein and kinesin-1-dependent movement of lipid droplets in fly
embryos [18].
To investigate whether mammalian BICD is involved in other
transport routes in addition to Rab6 vesicle trafficking, we
searched for partners of the cargo-binding domain of BICD2,
one of the two mammalian homologues of the fly BicD [8]. We
identified a component of the nuclear pore complex (NPC),
RanBP2 [19,20], as the major interacting partner of BICD2 C
terminus. RanBP2 (also known as NUP358) is a large protein,
which acts as docking factor in nucleocytoplasmic transport [21]
and is an E3 ligase for posttranslational modification with the
ubiquitin-like protein SUMO1 [22]. RanBP2 exists in a tight
complex with the sumoylated form of RanGAP1, the Ran
GTPase-activation protein, and targets it to the NPCs [23,24].
RanBP2 forms extended fibers at the cytoplasmic side of the NPC
and represents a good candidate for a link between the
cytoskeleton and the nuclear envelope (NE).
Previous studies showed that cytoplasmic dynein is specifically
recruited to the NE in late G2/mitotic prophase, where it
participates in NE breakdown (NEB) during mitotic entry ([25,26];
for review see [27,28]). Furthermore, NE-bound dynein is thought
to pull centrosomes towards the NE, through its minus-end-
directed motility, thereby contributing to proper attachment of
centrosomes to the NE [29,30]. In yeast, a dynein light chain is a
nucleoporin, but it likely acts at the NPC independently of the
dynein motor [31]. In C. elegans, dynein is anchored to the NE by
the nuclear membrane component SUN-1 and a hook protein
ZYG-12 [32]. Also in mammals, SUN1/2 and Syne/Nesprin-1/2
complexes, together with associated MT motors, are important to
maintain the connection between the centrosome and nucleus
during neuronal migration [33]. However, the molecular mech-
anism of G2-specific dynein interaction with the NE in dividing
mammalian cells has not yet been clarified.
Here, we show that BICD2 specifically associates with the NPCs
through RanBP2 in the G2 phase of the cell cycle and participates
in the recruitment of the dynein/dynactin complexes to these
structures. In addition, BICD2 associates with kinesin-1 [13] and
we show that while dynein pulls centrosomes and the nucleus
together during mitotic entry, kinesin-1 pushes them apart. During
late G2, cytoplasmic dynein activity predominates over kinesin-1
activity, and the centrosomes remain tightly associated with the
NE. Furthermore, we show that BICD2 not only acts to recruit
dynein to the NE but is also required for the oppositely directed
kinesin-1 activity, explaining why loss of BICD2 results only in a
mild defect in centrosome-nuclear attachment. These results
suggest that similar to most other MT motor cargos in animal
cells, the prophase cell nucleus is transported bi-directionally by a
molecular complex combining MT motors of opposite polarity.
Results
RanBP2 Directly Binds to BICD2 C Terminus
Our previous studies showed that the individual coiled coil
segments of BICD2 display strong association with their binding
partners, while the full-length molecule binds to the same proteins
less efficiently, suggesting that it may be autoinhibited [8,9,11].
Therefore, we used the C-terminal coiled coil segment of BICD2
(Figure 1A) as a bait to search for new BICD2 cargos. We linked
this BICD2 fragment to GFP and a biotinylation tag (Bio), a short
peptide sequence that can be modified by the addition of biotin
when expressed together with the biotin ligase BirA [34]. The
resulting Bio-GFP-BICD2-CT fusion was transiently expressed
together with BirA in HeLa cells, which were used for pull-down
assays with streptavidin beads (Figure S1). The resulting protein
complexes were analyzed by mass spectrometry (Table S1). The
most abundant newly identified potential BICD2 partner was the
NPC component RanBP2. RanGAP1, the sumoylated form of
which is known to form a tight complex with RanBP2 [23,24], was
also present among the isolated proteins in highly significant
amounts (Table S1).
The results of the pull-down assay were confirmed by co-
immunoprecipitation (co-IP) of endogenous RanBP2 with endog-
enous BICD2; an abundant Golgi-associated protein GM130
served as a negative control (Figure 1B). Further, we observed co-
IP of endogenous BICD2 with RanBP2 from nocodazole-arrested
HeLa cells, but neither BICD1 nor CLIP-170, another cytosolic
protein known to interact with dynactin [35], were coprecipitated
with RanBP2 in these conditions (Figure 1C). Next, we
investigated which domain of RanBP2 associated with BICD2.
RanBP2 is a protein of ,350 kDa, which contains a leucine-rich
region, four Ran-binding domains, eight zinc finger motifs, and a
C-terminal cyclophilin A-homologous region (Figure 1A). We
generated expression constructs of five RanBP2 fragments, which
Author Summary
Bidirectional microtubule-based transport is responsible
for the positioning of a large variety of cellular organelles,
but the molecular mechanisms underlying the recruitment
of microtubule-based motors to their cargoes and their
activation remain poorly understood. In particular, the
molecular players involved in the important processes of
nuclear and centrosomal positioning prior to the onset of
cell division are not known. In this study we focus on the
function of one of the mammalian homologues of
Drosophila Bicaudal D, an adaptor for the microtubule
minus-end-directed dynein-dynactin motor complex. Pre-
viously, Drosophila Bicaudal D and its mammalian homo-
logues were shown to act as linkers between the dynein
motor and mRNP complexes or secretory vesicles. Here, we
identify a new cargo for mammalian Bicaudal D2 (BICD2)–
the nucleus. We show that BICD2 specifically binds to
nuclear pore complexes in cells in G2 phase of the cell
division cycle. We also show that this interaction is
required for G2-specific recruitment of dynein to the
nuclear envelope and thus for proper positioning of the
nucleus relative to centrosomes prior to the onset of
mitosis. Further, our findings demonstrate that the motor
protein kinesin-1 opposes dynein’s activity during this
process and requires BICD2 for its activity. Our study
therefore reveals BICD2 as the critical molecular adaptor
that allows molecular motors to regulate nuclear and
centrosomal positioning before cell division.
BICD2 Targets Dynein to Nuclear Pores
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covered most of the RanBP2 sequence, as fusions to CFP and the
plasma membrane-targeting palmitoylation motif of GAP-43
(Figure 1A). With the exception of the N-terminal fragment 1,
these fusions were expressed well in mammalian cells. Using co-IP
from HEK293 cells, we found that the C-terminal domain of
BICD2 specifically interacted with RanBP2 fragment 3
(Figure 1D). This experiment also showed that BICD2-CT does
not interact with the overexpressed GFP-tagged RanGAP1
(Figure 1D), indicating that coprecipitation of RanBP2-RanGAP1
complex with BICD2-CT, observed by mass spectrometry, is due
to BICD2 interaction with RanBP2. The interaction between
BICD2 and RanBP2 is direct, since BICD2-CT and RanBP2
segment 3, purified from bacteria, specifically bind to each other in
a glutathione S-transferase (GST) pull-down assay (Figure 1E,F).
Remarkably, the same RanBP2 fragment was previously shown
to interact directly with kinesin-1 isoforms KIF5B and KIF5C
[36–38], supporting the notion that it is involved in MT motor
recruitment.
Next, we employed a yeast two-hybrid assay, which showed that
RanBP2 fragment 3 binds exclusively to the C-terminal part of
BICD2 and not to its N-terminal and middle segments (Figure 1G).
This is similar to the previously described interaction between
BICD2 and Rab6 [8,11] and is in contrast to kinesin-1 KIF5A,
which associates with the middle portion of BICD2 (Figure 1G)
[13].
Finally, we tested if fragment 3 of RanBP2 was sufficient to
recruit BICD2 C terminus to ectopic sites within the cell. For this,
RanBP2 fragments were artificially targeted to the plasma
membrane through addition of a palmitoylation motif, as
described above. The palmitoylation motif fusions of RanBP2
fragments displayed a strong association with the plasma
membrane, including filopodia, and also with the Golgi complex
(Figure 1H), but as expected, did not target to the NE. BICD2-CT
expressed in mammalian cells associates with the Golgi and
cytoplasmic vesicles, but not with the plasma membrane [8,11].
Interestingly, BICD2-CT was specifically recruited to the plasma
membrane by RanBP2 fragment 3 but not by other RanBP2
fragments (Figure 1H), suggesting that this domain of RanBP2 can
serve as a recruitment factor for BICD2.
RanBP2 Recruits BICD2 to NPCs during G2
We next investigated whether endogenous BICD2 and RanBP2
co-localize in HeLa cells and found that BICD2 specifically
associates with the NE in a subset of cells, where it largely overlaps
with the RanBP2 staining (Figure 2A). This localization pattern
was visible not only in cells subjected to fixations with
paraformaldehyde or a combination of cold methanol with
paraformaldehyde (which are optimal for preservation of the
Golgi- and vesicle-bound fraction of BICD2) but also after fixation
with cold methanol alone, which did not preserve the Golgi-bound
or the cytoplasmic pool of the protein (see below); it was further
enhanced by treating cells with the MT-destabilizing drug
nocodazole (Figure 2B–D). We hypothesized that the absence of
BICD2 staining at the NE in a subset of cells was caused by cell
cycle regulation. Indeed, all cells that showed BICD2 accumula-
tion at the NE were positive for cyclin B1, which is expressed
exclusively in G2 and mitosis, and ,75% cyclin B1-positive cells
showed BICD2 localization at the NE, indicating that BICD2
associates with the NE in the G2 phase (Figure 2A–D). G2-specific
recruitment to the NE was also observed in another human cell
line, U2OS cells (Figure S2A,B).
In addition to the NE, endogenous BICD2 also co-localized
with RanBP2 in puncta in the cytoplasm (Figure 2A,B). Compar-
ison with previous studies suggested that these puncta are
cytoplasmic stacks of NPCs known as annulate lamellae (AL)
[39]. Indeed, these puncta were stained by 4 additional markers
for NPCs: RanGAP1; the monoclonal antibody 414 (MAB414)
that reacts with several nucleoporins [40]; an antibody against
NUP214, an NPC component that binds to the cytoplasmic side of
the nuclear pores independently of RanBP2 [41], and YFP-tagged
POM121, a transmembrane NPC component that is also present
in AL (Figure S3) [42]. In line with the recruitment of BICD2 to
NPCs in the NE in G2 cells, we observed the association of BICD2
with the AL in cyclin B1-positive but not in cyclin B1-negative cells
(Figure 2A,B). These results are important as they support the view
that G2-specific recruitment of BICD2 to the NE is due to its
interaction with the cytoplasmic part of the NPCs and not some
other NE component.
Since we found that BICD2 directly interacts with RanBP2, we
examined whether the NE localization of BICD2 was RanBP2-
dependent. RanBP2 could be specifically depleted from HeLa and
U2OS cells without affecting the expression of BICD2 (Figure
S4A,B). Indeed, depletion of RanBP2 blocked recruitment of
BICD2 to the NE of G2 cells (Figure 2C,E; Figure S2A,B).
Based on the results described above, BICD2 is expected to
specifically associate with individual NPCs on the NE. Indeed, both
Figure 1. BICD2 interacts directly with RanBP2. (A) Schematic representation of the domains of RanBP2 and BICD2 and their fragments used for
binding studies. (B) Co-IP of endogenous BICD2 and RanBP2 from HeLa cells. IPs were performed with antibodies against BICD2 or the control IgG
and analyzed by Western blotting with the indicated antibodies. 2.5% of the input was loaded on gel. RanBP2, but not the negative control, GM130, is
co-precipitated with BICD2. (C) Co-IP of endogenous RanBP2 and BICD2 from nocodazole-arrested HeLa cells. IPs were performed with antibodies
against RanBP2 or the control IgG and analyzed by Western blotting with the indicated antibodies. 3% of the input was loaded on gel. BICD2 is co-
precipitated with RanBP2, while its close homologue BICD1 and another dynactin-binding protein, CLIP-170, are not. (D) Co-IPs from HEK293 cells co-
transfected with CFP-tagged RanBP2 fragments or GFP-RanGAP1 and mCherry-fused BICD2-CT. IPs were performed using mouse anti-GFP antibodies
and analyzed by Western blotting using rabbit anti-GFP or anti-BICD2 antibodies. BICD2-CT and the IgG bands are indicated by an arrowhead and an
arrow. BICD2-CT is coprecipitated with RanBP2 fragment 3, but not with other RanBP2 fragments or RanGAP1. (E) HIS-tagged BICD2-CT, GST, and GST
fusions of RanBP2 fragments 3 and 4 were purified from E. coli and analyzed by SDS-polyacrilamide gel electrophoresis and Coomassie staining. (F)
GST pull-down assays with the indicated RanBP2 fusions and purified HIS-tagged BICD2-CT, which was detected by Western blotting with anti-HIS tag
antibodies. 10% of the input and the bound fractions were loaded on gel. Using 0.8 mM BICD2-CT and 1.4 mM GST-RanBP2 fragment 3, an almost
quantitative binding was observed. This experiment confirms a direct interaction between RanBP2 fragment 3 and BICD2-CT. (G) Yeast two-hybrid
analysis. BICD2 fragments were linked to GAL4 activation domain and tested in a pairwise fashion for interaction with RanBP2, GTP-bound Rab6A
(Q72R), kinesin-1 (KIF5A), and kinesin-4 (KIF21B) tail regions cloned into LexA fusion vector. Interaction strength was scored according to the time
needed for b-galactosidase reporter to generate visible blue-colored yeast colonies on X-Gal containing filters: +++0–30 min, ++30–60 min, +60–
180 min and - no b-galactosidase activity. Similar to the previously characterized BICD2 partner Rab6, RanBP2 fragment 3 (2147–2287) specifically
interacts with BICD2-CT, but not with other parts of BICD2. (H) HeLa cells were co-transfected with the indicated plasma membrane targeted CFP-
RanBP2 fusions and HA-tagged BICD2-CT, fixed with paraformaldehyde, and stained with anti-HA antibodies. CFP fluorescence was visualized directly.
CFP-tagged palmitoylated RanBP2 fragments are present on the plasma membrane (upper panels), while BICD2-CT (upper panels) localizes to the
Golgi and cytoplasmic vesicles (middle panels). RanBP2 fragment 3, but not the other RanBP2 fragments, recruits BICD2-CT to the plasma membrane
(see overlay in the bottom panels).
doi:10.1371/journal.pbio.1000350.g001
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Figure 2. BICD2 associates with the NE and AL in G2 phase in a RanBP2-dependent manner. (A) HeLa cells were transfected with a
control siRNA, fixed with cold methanol followed by paraformaldehyde 3 d later, and stained for endogenous BICD2, RanBP2, and cyclin B1.
Note that in the cyclin B1-positive cell, BICD2 and RanBP2 co-localize at the NE and at a perinuclear spot that is an accumulation of AL. (B) HeLa
cells were treated with 10 mM nocodazole for 1 h and stained as described for (A). Note that BICD2 strongly stains the NE and cytoplasmic NPC-
positive dots (AL) in the cyclin B1-positive but not the cyclin B1 negative cells. (C) HeLa cells that were either treated with 10 mM nocodazole or
transfected with control siRNAs or a mixture of RanBP2 siRNAs #1 and #2 were stained as described for (A), and the percentage of cyclin B1-
positive cells showing BICD2 accumulation at the NE was counted. In case of RanBP2 knockdown, only the cells in which RanBP2-specific nuclear
staining was reduced to background levels were included in the quantification. Error bars represent SD; the number of experiments for each
condition is shown in parentheses below the graph; ,40–100 cells were counted per experiment. (D) Fluorescence intensity ratio between NE
and the adjacent cytoplasm in cyclin B1 positive and negative cells (,50 cells per measurement); cells were either untreated or treated with
10 mM nocodazole for 1 h. Measurements were performed in a region of 0.3 by 30 mm at the border between cytoplasm and the nucleus
(NE) and in a directly adjacent region (cytoplasm). Error bars represent SEM. (E) HeLa cells were transfected with a mixture of RanBP2 siRNAs #1
and #2, fixed, and stained as described for (A). Note that the two cyclin B1-positive cells that have strongly reduced RanBP2 levels show no
accumulation of BICD2 at the NE.
doi:10.1371/journal.pbio.1000350.g002
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full-length BICD2 and GFP-tagged BICD2-CT co-localized with
individual NPCs on the NE in cells that were pre-extracted with a
Triton X-100-containing buffer to reduce the cytoplasmic pool of
the GFP-BICD2 fusions (Figure S5). Similarly, colocalization of
endogenous BICD2 with individual NPCs was also observed in
methanol-fixed cells, in which cytosolic BICD2 signal has been
removed (Figure 3A,B). Fluorescent intensity profiles showed that
most of the individual NPCs in the NE (stained with MAB414) also
showed a peak of BICD2 fluorescence (Figure 3B,C). The
significance of the overlap was confirmed by quantitative analysis:
the coefficient of linear correlation between properly aligned
MAB414 and BICD2 images was, on average, ,0.5, while it was
close to zero when one of the two images was rotated, indicating
that observed colocalization between the two markers was not due
to fortuitous overlap between abundant dot-like patterns
(Figure 3D–G). Taken together, our results show that BICD2
Figure 3. BICD2 to localizes to the nuclear pores at the NE. (A) HeLa cells were fixed with cold methanol and stained with antibodies against
BICD2 and nucleoporins (MAB414). These panels show focal planes in the middle part of the nuclei. (B) Enlargements of the flattened NE surface from
the same cells as in (A) (the area from which the enlarged image is taken is indicated in (A) by a white rectangle). The insets show further
enlargements, in which individual NPC can be distinguished. Colors used for the overlays are indicated above the corresponding images. Note that
most NPC dots display signal in both channels, indicating that BICD2 and MAB414 antigens (NPCs) co-localize. (C) Representative fluorescence
intensity profile of BICD2 (green) and MAB414 staining (red) at the NE surface. The profile was obtained using Linescan function of MetaMorph at the
position indicated by a blue line in (B). Vertical axes are in arbitrary units. Note that most peaks are present in both BICD2 and MAB414 channels,
although their intensities often differ, in agreement with the fact that BICD2 is not a nucleoporin. (D) Correlation between BICD2 and MAB414 signals
in Figure 3B. The intensity of each pixel in the green and red channel is represented by a dot. (E,F) The same images and analysis as in (B) and (D), but
with the MAB414 panel rotated by 180u. Note that there is no co-localization between the green and red signals and no correlation is visible in the
plot. (G) Average coefficient of linear correlation between BICD2 and MAB414 signals, determined from plots such as in (B) and (D) obtained for 19
cells. Note that the coefficient is much higher for properly aligned images compared to rotated ones, indicating that co-localization is not spurious.
Error bars represent SD.
doi:10.1371/journal.pbio.1000350.g003
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binds RanBP2 both in vitro and in vivo, localizes to NPCs (both in
the NE and in AL) in G2 cells, and that this recruitment to NPCs
depends on RanBP2. It is therefore likely that a direct interaction
between RanBP2 and BICD2 links BICD2 to the NE in G2 cells.
BICD2 Recruits the Dynein-Dynactin Complex to the NE
and AL during G2
Although previous studies showed that BICD2 strongly co-
localizes with Rab6 on the Golgi apparatus and cytoplasmic
vesicles [10,11], this was not the case in G2 cells where BICD2
accumulated at the NE (Figure 4A). This conclusion was
confirmed by staining nocodazole-treated cells, where the
dispersion of the Golgi and nocodazole-induced enlargement of
the AL permitted better distinction of protein localization in
different cytoplasmic structures (Figure 4B). In the cells where
BICD2 associated with Rab6-bound membranes, it did not stain
the NE or the AL. However, in the cells where BICD2 localized to
the NE and AL, it displayed virtually no colocalization with Rab6
(Figure 4B). Combined with the results described above, these
observations indicate that BICD2 switches from Rab6-bound
membranes to the NPCs in G2 phase cells.
We next investigated whether the dynein-dynactin complex is
recruited to the NE along with BICD2. In untreated HeLa cells,
both dynein and dynactin show diffuse cytosolic localization as
well as an accumulation at the MT plus ends and the centrosomes
(unpublished data). However, in nocodazole-treated cells, coloca-
lization of dynein and dynactin with BICD2 could be detected in
specific cytoplasmic structures [8]. While in the majority of cells
these structures coincided with Rab6-positive Golgi fragments, in
all cells in which BICD2 co-localized with RanBP2, both dynein
and dynactin co-localized with BICD2 on RanBP2-positive
membranes, suggesting that the association of BICD2 with dynein
and dynactin is maintained when BICD2 switches from Rab6 to
RanBP2 (Figure 4C,D; Figure S6A). Because both BICD2 and
RanBP2 were shown to bind to kinesin-1, we also attempted to
investigate the localization of its isoforms. Although we were able
to specifically detect the predominant kinesin-1 isoform, KIF5B, in
HeLa cells (as confirmed by siRNA-mediated depletion), it
displayed a largely diffuse distribution, and no clear accumulation
of this protein could be detected at the NE or AL with or without
nocodazole treatment (unpublished data).
Since BICD2 can directly bind both the NPCs and the dynein-
dynactin complex, we next investigated whether BICD2 is required
to recruit dynein and dynactin to the NPCs. Because we could not
stain cells simultaneously for cyclin B1 and dynactin or dynein, we
used an antibody against histone H3 phosphorylated at serine 10
(phospho-H3), which becomes highly phosphorylated in late G2/
prophase cells [43]. All phospho-H3-positive cells displayed very
strong recruitment of endogenous dynactin and dynein to both the
NE and AL (Figure 4E,F; Figure S6B,C). Strikingly, this
recruitment was inhibited by depletion of BICD2, but not BICD1
(Figure 4E,F; Figure S6B,C; and unpublished data), demonstrating
that BICD2 is required for the association of dynein and dynactin
with the NPCs in prophase cells. In contrast, BICD2 was recruited
normally to the NPCs after depletion of either the dynein heavy
chain (HC) or dynactin large subunit p150Glued (see below). These
results suggest that BICD2 directly links the dynein/dynactin
complex to the NE through its interaction with RanBP2.
Dynein and Kinesin-1 Control Relative Positioning of the
Nucleus and the Centrosomes before Mitotic Entry
Since dynein associates with the NE in G2 phase, we next
examined how its depletion affected the relative position of the
nucleus and centrosomes during mitotic entry. Because the
perinuclear MT cytoskeleton is very dense and therefore difficult
to analyze in HeLa cells, we used U2OS cells, in which MT arrays
are more sparse and centrosome-centered. In control cells, the
centrosomes were always located very closely to the NE in
prophase (Figure 5A,B). In contrast, in dynein-depleted cells the
nucleus and the centrosomes were almost always found in opposite
cell corners during prophase (Figure 5A,B). Similarly, live cell
imaging of U2OS cells stably expressing mCherry-a-tubulin
showed that in control cells centrosomes migrate along the NE,
to the opposite sides of the nucleus just before mitotic entry (Figure
S7A), allowing spindle assembly to initiate around the DNA. In
contrast, in ,90% of dynein-depleted cells, centrosomes and the
nucleus had moved apart substantially at the time NEB occurred,
and therefore the DNA was not positioned in between the
centrosomes when spindle assembly initiated (Figure S7A;
Figure 5B); similar results were obtained in HeLa cells after
dynein or dynactin depletion (Figure S7B, Videos S1–S3).
Importantly, not only the centrosomes lost their central position
(which could be explained by the loss of interactions between MT
ends and the cell cortex upon dynein depletion [44]), but also the
nucleus was rapidly pushed into one of the cell corners, towards
MT plus ends (Figure 5C–E, see Videos S4–S7). Nuclear
movement was initiated 5464 min before NEB, and the average
velocity of movement was ,160 nm/min (Figure 5E). The final
distance between the two centrosomes at the time of NEB was the
same in control and dynein-depleted cells (9.861.0 mm in control
and 9.860.6 mm in dynein-depleted cells (mean6SD)), consistent
with our previous findings [45], indicating that centrosome
separation does not require linkage to the NE or dynein function.
To rule out that the detachment of centrosomes from the
nucleus was due to defects arising after long-term dynein
inhibition, we microinjected U2OS cells that were in late G2
with function blocking antibodies against dynein intermediate
chain (IC). As expected, dynein-inhibiting antibodies, but not the
control antibodies, induced rapid separation of the nuclei and the
centrosomes (Figure 5F–H), demonstrating that dynein activity is
required during late G2 to maintain the connection between
centrosomes and the NE. Very similar results were obtained after
microinjection of the first coiled coil fragment of the dynactin large
subunit p150Glued (CC1), which is known to disrupt dynactin-
dependent dynein mediated processes (Figure S8) [46].
Pushing a relatively large nucleus into a flattened corner of a
cultured cell would require substantial force, which is most likely
generated by kinesin motors attached to the nucleus and moving
to MT plus ends. We hypothesized that KIF5B might be involved
in this process because it interacts with both BICD2 and RanBP2.
Indeed, co-depletion of KIF5B together with dynein fully restored
centrosome and nuclear position at NEB (Figure 5B, Figure S7A;
for control of double knockdown efficiency, see Figure S4C),
indicating that it is indeed driving the separation of nuclei and
centrosomes in dynein-depleted cells. Taken together, these results
suggest that the prophase cell nucleus is transported bi-
directionally by the opposing activities of dynein and kinesin-1,
similar to many other cargoes.
BICD2 and RanBP2 Are Required for Maintenance of the
Association between the NE and the Centrosomes in
Prophase Cells
Since we showed that BICD2 is required for dynein and
dynactin recruitment to the NPCs in G2 phase, we next
investigated whether its depletion has an influence on the relative
positioning of the centrosomes and the nuclei. Similar to HeLa,
U2OS cells express both BICD2 and BICD1, which can be
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depleted by a number of different siRNAs without affecting the
expression of RanBP2 or MT motors (Figure 6A; Figure S4C).
Depletion of BICD2 induced the detachment of the centro-
somes from the nucleus in prophase (Figure 6B,C(a–c)). This effect
was specific, since it was not observed after depletion of BICD1 or
KIF5B, but it was much less severe than after dynein knockdown
(Figure 6B,C(a–c)). Cells with simultaneous knockdown of BICD1
and BICD2 displayed a phenotype similar to that of BICD2
depletion alone, confirming the view that BICD1 does not
contribute much to centrosome positioning (Figure 6C(c)). Cen-
trosome detachment from the NE was also observed in cells
overexpressing BICD2-CT, which is expected to uncouple
dynein/dynactin from BICD2-containing cargos (Figure 6B,C(d))
[11]. Interestingly, RanBP2 depletion, which prevents BICD2
recruitment to the NE (Figure 2C,E; Figure S2A,B) also caused an
increase in the distance between the nuclei and the centrosomes,
while the depletion of another cytoplasmic nucleoporin, NUP214,
had no effect (Figure 6C(e); Figure S4B).
To further prove that BICD2 can exert a direct effect on
centrosome positioning through its localization at the NE, we
constructed a fusion protein in which we attached the N-terminal
portion of BICD2, including the dynein and kinesin-1 binding
sites, to the C-terminal KASH (Klarsicht, ANC-1, Syne
Homology) domain-containing region of nesprin-3, which is
targeted to the NE by SUN proteins [47]. This fusion localized
specifically to the NE and enhanced the accumulation of dynactin
at the NE (Figure 6D). Importantly, the expression of the BICD2-
NT-nesprin-3 fusion completely suppressed centrosome detach-
ment in RanBP2-depleted prophase cells (in which endogenous
BICD2 is no longer targeted to the NE, see Figure 2C,E), even at
very low expression levels (Figure 6C(f)). Taken together, these
results support the view that BICD2 can recruit MT motors to the
NE and regulate the relative localization of the nucleus and the
centrosomes.
Since the distance between the centrosomes and the nucleus in
BICD2 or RanBP2 knockdown cells was much smaller than in the
case of dynein knockdown, it appears that there is no severe
imbalance between the activities of dynein and kinesin-1 at the NE
under these conditions. These results suggest that BICD2 is not
only involved in dynein function at the NE but might also be
required for proper kinesin-1 function.
If this idea is correct, BICD2 depletion should block the kinesin-
1 driven separation of centrosomes from the nuclei observed after
dynein depletion. Indeed, co-depletion of BICD2 with dynein
strongly reduced the distance between the centrosomes and the
nuclei observed after dynein depletion alone (see Figure 5B). This
rescue of centrosome-nuclear attachment was not due to a
decreased efficiency of dynein depletion (see Figure S4C);
moreover, the mitotic arrest in cells depleted of both BICD2
and dynein HC was similar to that observed for single dynein HC
knockdown (unpublished data), further confirming that dynein
function was similarly perturbed in both cases and indicating that
BICD2 depletion does not help to overcome later mitotic
phenotypes associated with dynein loss.
Eg5 Pushes the Centrosomes Away from the Nucleus in
BICD2-Depleted Cells
Why do centrosomes detach from the NE in prophase after
BICD2 knockdown if both kinesin-1 and dynein activities are
reduced? We recently found that the plus-end directed kinesin-5
Eg5, known to slide antiparallel MTs [48], pushes centrosomes
apart during prophase [45]. Thus, Eg5-dependent sliding forces
might drive the centrosomes away from the nucleus when it
becomes uncoupled from dynein and kinesin-1 due to BICD2
depletion. In line with this idea, inhibition of Eg5 with S-trityl-L-
cysteine (STLC) significantly suppressed centrosome detachment
caused by BICD2 depletion, indicating that Eg5 is at least in part
responsible for pushing the centrosomes away from NE in BICD2-
depleted prophase cells (Figure 6C(g)). Taken together, our data
show that centrosome separation and positioning at the opposite
sides of the NE at the mitotic onset is driven by forces generated by
dynein, kinesin-1, and Eg5.
G2-Specific Movement of AL Confirms the BICD2-
Dependent Link between NPCs and MT Motors
Do dynein and kinesin-1 indeed attach to the NE through
NPCs? If this were true, the positioning of AL, which contain
cytoplasmic NPC components but are devoid of many other NE-
specific proteins, such as the nuclear lamina and the proteins that
are linked to it, should be affected by the depletion of MT motors.
AL are relatively small structures that are normally located in the
central cytoplasm; they can potentially serve as a sensitive readout
for the forces exerted on them by cytoplasmic motors. In control
cells, AL are predominantly located around the Golgi apparatus in
G1 and S-phase; in G2 they shift towards the centrosome and
gradually disappear ([49], Figure 7A, and see also Figures 2A, 4A,
and Video S8). The depletion of the dynein HC or dynactin
subunit p150Glued induced relocalization of AL to the cell
periphery of cyclin B1-positive cells (towards MT plus ends;
Figure 7A). Using a cell line stably expressing GFP-tagged
RanGAP1 (Figure S9), we observed that the timing of movement
of the AL to the cell periphery coincided almost exactly with the
timing of peripheral displacement of the nucleus in cells lacking
dynein activity (,1 h before NEB) (Figure 7B, Video S9).
Furthermore, peripheral displacement of AL in dynein-depleted
cells was completely dependent on kinesin-1 activity (Figure 7C),
similar to displacement of the nucleus in these cells (see Figure 5B).
Together, these results indicate that the forces that act to position
the AL are mechanistically similar to those that position the
nucleus. Consistent with this, knockdown of KIF5B caused a very
strong accumulation of AL near centrosomes, where MT minus
ends are located in G2 (Figure 7A and Figure S10A,B,C), and
centrosomal accumulation of AL was, in turn, dependent on
dynein activity (Figure 7C). The analysis of the timing of AL
Figure 4. BICD2 is required for targeting dynein/dynactin to the NE and AL. (A–D) Control HeLa cells or HeLa cells treated with 10 mM
nocodazole for 1 h were fixed with paraformaldehyde (A–C) or cold methanol (D) and stained for the indicated endogenous proteins. Dynactin is
visualized with an antibody to p150Glued and dynein with an antibody to dynein IC. Colors used for the overlays are indicated above the
corresponding images. Note that BICD2 shows two types of localization: it colocalizes either with Rab6 or with RanBP2. In cells where BICD2
associates with RanBP2-positive NE and AL, dynein and dynactin are also targeted to these structures. (E) HeLa cells were transfected with a control
siRNA (upper panels) or BICD2#1 siRNA (bottom panels). Three days later, cells were treated with 10 mM nocodazole for 5 h, fixed with cold
methanol, and stained for endogenous RanBP2, phosphorylated histone H3, and dynein IC. NE staining by dynein antibodies is indicated by an arrow.
Colors used for the overlays are indicated above the corresponding images. Note that dynein is enriched at the NE and annulate lamellae in control
phospho-histone H3 positive cell, but not in BICD2-knockdown cell. (F) Percentage of HeLa cells positive for phosphorylated histone H3 that show
strong accumulation of dynein IC at the RanBP2-positive NE and AL in control or BICD2-depleted cells 3 d after siRNA transfection. Only the cells with
clearly visible AL were included in the quantification. Error bars represent SD; ,25–30 cells were counted in two experiments.
doi:10.1371/journal.pbio.1000350.g004
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movement in kinesin-1-depleted cells showed that centrosomal
accumulation started ,3 h before NEB (Figure 7B, Video S10),
which corresponds very well to the time at which BICD2 and
dynein are recruited to NPCs, further suggesting that BICD2 and
dynein recruitment to NPCs in G2 phase induces movement of
these structures towards MT minus ends. Taken together, these
results show that, similar to the nucleus, the position of AL in G2
phase is controlled by the antagonistic activities of dynein and
kinesin-1 and further suggest that both dynein and kinesin-1 act to
position the nucleus through their effect on NPCs, rather than
through other NE-associated proteins.
We also used AL displacement to strengthen our conclusions
that BICD2 controls both dynein- and kinesin-1-dependent
movement of NPCs. Importantly, BICD2 remained strongly
enriched at the AL and the NE when dynein, dynactin, or KIF5B
were depleted, indicating that BICD2 association with the NPCs
is independent of MT motors (Figure 7A). In control G2 phase
cells, AL often displayed some perinuclear accumulation in the
centrosome region (see Figures 2A, 7C, Figure S11A,B). However,
BICD2 depletion reduced perinuclear accumulation of AL in G2
phase (Figure 7C, Figure S11A,B). These findings were confirmed
by observing the behavior of AL by time-lapse microscopy after
BICD2 knockdown, where AL remained randomly dispersed until
the beginning of mitosis (Figure S11C, Video S11). These results
further implicate BICD2 in the G2 specific activation of MT
minus-end-directed force generation on NPCs. Furthermore, the
shift of AL to the cell center or the cell periphery caused by
kinesin-1 and dynein depletion, respectively, was strongly inhibited
by co-depletion of BICD2 but not by control siRNAs or siRNAs
against BICD1 or Rab6 (Figure 7C, Figures S11C, S12; Videos
S12, S13). These results demonstrate that BICD2 is required for
the G2-specific movement of the AL by both kinesin-1 and dynein
and strongly support the notion that both dynein and kinesin-1
control nuclear movement by acting through BICD2 on the NPCs.
We have also investigated if other cytoskeletal systems, in
addition to MTs, are directly involved in the G2-specific processes
described above but found no evidence for direct involvement of
the actin cytoskeleton or the intermediate filaments, keratin or
vimentin, in the G2-specific nuclear-centrosome positioning
pathway that relies on dynein and kinesin-1 (Figures S13, S14).
Discussion
During cell division the MT cytoskeleton and membrane
organelles undergo a severe reorganization, which proceeds in a
highly regulated manner. In many cell types, the two centrosomes
move apart while maintaining their attachment to the NE. This
helps to form the bipolar mitotic spindle around the chromosomes
after NEB. In this study, we have obtained insight into molecular
mechanisms that control the relative positioning of the nucleus and
the centrosomes at mitotic onset. We show that the dynein/
dynactin adaptor BICD2 is specifically recruited to the NPC in G2
phase through a direct interaction with the NPC component
RanBP2. In its turn, BICD2 is important for accumulation of
dynein and dynactin at the nuclear pores in prophase cells. In line
with previously published data (reviewed by [27,28]), we find that
cytoplasmic dynein is the major player responsible for the nucleus-
centrosome attachment, but unexpectedly, we find that kinesin-1
also participates in this process by antagonizing dynein function.
Since BICD2 and RanBP2 are likely involved in linking both MT
motors to the NPCs, depletion of either protein causes only mild
centrosome detachment from the nucleus.
Our previous studies showed that BICD2 associates with MT
motors through its N-terminus and the middle portion, while the
C terminus is the cargo-binding site [9,11,13]. Here we identified
a new cargo for BICD2, the nucleoporin RanBP2, which binds to
the same domain of BICD2 as the small GTPase Rab6. Our data
suggest that the interaction of BICD2 with the two cargos is
temporally regulated during the cell cycle: during G1 and S phase,
BICD2 appears to associate predominantly with Rab6, while in
G2 it binds mostly to the NPCs (Figure 8). It is currently unclear
how this switch is controlled, but it is likely that mitotic kinases are
involved.
Both during Rab6 vesicle trafficking and in nuclear positioning,
BICD2 participates in transport processes that involve the
opposing functions of cytoplasmic dynein and kinesin-1. The
predominating motor in the two processes is different: Rab6
vesicles are exocytotic carriers that preferentially move to MT plus
ends, suggesting that kinesin-1 activity is dominant, while the
nucleus and AL are mainly pulled by dynein (Figure 8). This
indicates that BICD2 participation by itself is insufficient to
determine direction of movement; therefore, additional factors or
posttranslational modifications are likely to be involved. While it
may appear strange that the two opposite polarity motors act
together in processes that mostly depend on only one of them, this
arrangement seems to represent a fundamental property of MT
motor systems most likely required to allow flexibility and permit
regulation of cargo distribution [3,4]. Our study shows that even
the positioning of a very large cargo, such as the cell nucleus, is no
exception to this rule.
The mechanism underlying kinesin-1 recruitment to BICD2-
bound NPCs is unlikely to be explained solely by the binding
between BICD2 and kinesin-1 [13], since RanBP2 can directly
bind to kinesin-1 as well [36,37]. Intriguingly, both BICD2 and
kinesin-1 interact with the same region of RanBP2; whether these
interactions are competitive or cooperative and what consequenc-
es this has on the architecture of the motor complexes remains to
be determined.
It is clear that RanBP2 and BICD2 are not the only proteins
participating in the motor recruitment and/or activation impor-
Figure 5. Dynein inactivation causes rapid separation of nuclei and centrosomes in G2. (A) U2OS cells were transfected with the control
or DHC#3 siRNAs, fixed with cold methanol, and stained for a-tubulin (green in overlay) and c-tubulin (red in overlay), as well as DNA (DAPI, blue in
overlay). Note that centrosomes are located close to the nucleus in control cells but are removed far away from the nucleus in dynein-depleted cells.
(B) mCherry-a-tubulin stable U2OS cell line was imaged with a 3 min time interval 2.5 d after transfection with the indicated siRNA mixtures, and the
distance between centrosomes and the nucleus at the time of NEB was measured. Error bars represent SD. The number of experiments is indicated in
parentheses below the graph. ,20 cells per experiment were analyzed. (C) mCherry-a-tubulin stable U2OS cells were imaged with a 3 min interval
2.5 d after transfection with DHC#1 siRNA. Nuclei and centrosomes undergo G2-specific displacements (indicated by asterisks and arrows,
respectively), resulting in their separation. (D,E) Quantification of displacement of nuclei and centrosomes starting from the moment when G2-
specific enhanced nucleation of MTs at the centrosome became visible (D), and velocity of nuclear movement during 1 h before NEB (E). Nuclear
movement in dynein-depleted cells was initiated 5464 min (mean6SD) before NEB. Measurements were performed in 10 cells in 3 independent
experiments. (F–H) U2OS cells stably expressing mCherry-a-tubulin were microinjected with antibodies against dynein IC (70.1) or the Myc tag. Late
G2 cells were chosen based on the presence of separated centrosomes. (F) An example of nucleus-centrosome separation after microinjection with
dynein-inhibiting antibodies. (G,H) Distance between the nucleus and the centrosomes (G) and percentage of cells showing strong centrosome
detachment (H) at 30 min after microinjection.
doi:10.1371/journal.pbio.1000350.g005
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Figure 6. Depletion of BICD2 and RanBP2 causes centrosome detachment in prophase U2OS cells. (A) Western blots with the indicated
antibodies were performed with equal amounts of extracts of U2OS cells 3 d after transfection with the indicated siRNAs. Note that BICD1 antibody
cross-reacts with BICD2 (arrows). Both BICD proteins can be independently depleted, although BICD1#1 siRNA causes some co-depletion of BICD2.
Levels of dynactin, dynein, KIF5B, and RanBP2 are not significantly affected BICD knockdown. (B) U2OS cells were transfected with BICD2#1 and
BICD1#1 siRNAs (upper panel) or with GFP-BICD2-CT, fixed with cold methanol, and stained for a-tubulin and c-tubulin, as well as DNA (DAPI). Colors
used for the overlays are indicated above the corresponding images. Note centrosome detachment caused by the loss of BICD function through
siRNA-mediated depletion or overexpression of the dominant negative mutant BICD2-CT. (C) The distance between the nucleus and the centrosomes
in fixed prophase U2OS cells under different conditions. (a,b) Cells were transfected with the indicated siRNAs against dynein HC or KIF5B. (c) Cells
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tant for centrosome-nuclear attachment. First, other parts of the
NPCs, additional dynein accessory factors, such as LIS1 and
NUDE [50], and cell cycle-dependent regulators of motor
activation, like CDKs or Plk1, are likely to be involved. This view
is supported by the observed timing of binding and transport steps.
BICD2 associates with the NPCs early in G2; this results in dynein
activation that is sufficient to cause strong AL accumulation
around the centrosome in the absence of kinesin-1 at ,3 h before
NEB. At a later stage (,1 h before NEB), additional motor
activation likely takes place; this is reflected by the peripheral
displacement of the AL, the nucleus, and the centrosomes in
dynein-depleted cells. Furthermore, Eg5 becomes active during
prophase and pushes centrosomes apart. The forces induced by
Eg5-dependent centrosome separation are kept in check by the
complex of RanBP2-BICD2-dynein that prevents centrosome
detachment from the nucleus while allowing centrosomes to
separate.
Second, KASH domain proteins such as nesprins are essential
for attachment of nuclei to the cytoskeleton in different systems
[33,51,52]. We observed that the displacement of endogenous
nesprins from the NE indeed affected relative positioning of the
nucleus and centrosomes in G2 phase, but the effect was much less
severe than that of dynein depletion (Tanenbaum, unpublished
data). Moreover, nesprin displacement from the NE could not
block kinesin-1-mediated nuclear displacement in dynein-depleted
cells (Splinter, unpublished data), indicating that in contrast to
certain epithelial cells [53], in cultured U2OS and HeLa cells
nesprins are not essential for attachment of kinesin-1 to the NE.
Nesprins bind to the NE through SUN proteins, which were
shown to interact with nuclear pores [54], and may therefore
participate in the formation of the MT motor assemblies at the NE
together with nucleoporins. It is likely that the relative importance
of different molecular links between the NE and MT motors
depends on the cell type and differentiation state.
What is the function of the complex molecular events described
in this study? Clearly, positioning of the centrosomes at the
opposite sides of the nucleus at NEB would decrease the chance
that a kinetochore is captured by MTs emanating from both poles
(merotelic attachments), which can result in chromosome
missegregation and aneuploidy, hallmarks of cancer [55].
Furthermore, spindle assembly in mammalian cells is controlled
by both centrosome- and chromatin-dependent pathways, in
which centrosomes are potent MT nucleation sites and chromatin
can both nucleate and stabilize MTs. When centrosomes are
positioned too far away from chromatin, newly nucleated MTs are
unstable and as a consequence spindle assembly might be delayed.
Indeed, loss of dynein results in a,15 min delay in bipolar spindle
assembly, which can be rescued by restoring the relative
positioning of centrosomes and the nucleus at mitotic entry
through co-depletion of kinesin-1 (Tanenbaum, unpublished data).
A mechanism coupling centrosomes to the nucleus at mitotic onset
could become even more important in very large cells like
fertilized oocytes, in which the distance between centrosomes and
chromosomes could become so extensive that centrosomes could
no longer contribute to spindle assembly.
In addition, the interaction of dynein with the NPCs through
BICD2 could help to tear apart the NE [26,56], a possibility that
was not addressed here. Furthermore, dynein-mediated coupling
between the nucleus, MTs, and the centrosome plays an important
role during migration of differentiated cells [57]. In flies, BicD is
involved in MT and dynein/dynactin-dependent positioning of
the oocyte and photoreceptor nuclei [7], and since BICD2 is
ubiquitously expressed during mammalian development (Akhma-
nova, unpublished data), it would be interesting to know if it plays
a similar role in mammals.
Materials and Methods
Expression Constructs and siRNAs
We used the following previously described expression vectors:
GFP-BICD2 [8], HA-BICD2-CT [11], myc-KIF5B [13], BirA [58]
(a gift of D. Meijer, Erasmus MC, Rotterdam, The Netherlands),
mCherry-a-tubulin [59] (a gift of R. Tsien, UCSD, San Diego, CA,
USA). Biotinylation and GFP-tagged BICD2 C terminus (Bio-GFP-
BICD2-CT, BICD2 amino acids 487–820, accession number
CAC51393) was generated in pEGFP-C2 (Clontech) by cloning at
the NheI and AgeI sites in front of the GFP a linker encoding the
amino acid sequence MASGLNDIFEAQKIEWHEGGG. CFP-
tagged RanBP2 fragments with the N-terminal palmitoylation signal
derived from GAP-43 were generated in a modified version of the
pECFP-N1 vector (Clontech) by a PCR based strategy. GFP-
BICD2-NT-nesprin-3 fusion was generated by attaching the amino
acids 582–975 of nesprin-3 (accession number NP_001036164, [60];
a gift of A. Sonnenberg, Netherlands Cancer Institute, Amsterdam)
to the C terminus of GFP-BICD2-NT (amino acids 1–594 of
BICD2 [9]). GFP-RanGAP1 was generated in pEGFP-C1 by
inserting into it the BglII-SmaI fragment of KIAA1835 (accession
number AB058738, a gift of Kazusa DNA Research Institute,
Japan). POM121 fused to a triple YFP tag [42] was a gift of Dr. E.
Hallberg (So¨derto¨rns University College, Huddinge, Sweden).
We used the following siRNAs: KIF5B#1, 59-GCCUUAUG-
CAUUUGAUCGG (siRNA 118426, Ambion), KIF5B#2, 59-
GCACAUCUCAAGAGCAAGU (siRNA 118427, Ambion), dy-
nein HC DHC#1 59-CGUACUCCCGUGAUUGAUG (siRNA
118309, Ambion), DHC#2 59-GCCAAAAGUUACAGACUUU
(siRNA 118311, Ambion), DHC#3 59-GGAUCAAACAUGAC-
GGAAU, RanBP2#1 59-GGACAGUGGGAUUGUAGUG [61],
RanBP2#2 59-CACAGACAAAGCCGUUGAA, RanBP2#3
Dharmacon SMARTpool, p150Glued 59 GUAUUUGAAGAUG-
GAGCAG, BICD2#1 59-GGAGCUGUCACACUACAUG,
BICD2#2 59-GGUGGACUAUGAGGCUAUC, BICD1#1 59-
CCUUAAUGCCAUAAUCCGG, BICD1#2 59-GCAAAGAG-
CCAAUGAAUAU, BICD1#3 59-GCAACUGUCUCGUCA-
AAGA, NUP214 59 GUCACGGAAACAGUGAAAG [41]. As a
control we used a previously described scrambled CLASP1
siRNA, the siRNA against luciferase [62], or the siRNA to GAPD
(control Dharmacon SMARTpool).
were transfected with the indicated siRNAs against BICD1 and/or BICD2. (d) Cells were transfected with GFP-BICD2-CT. (e) Cells were transfected with
the indicated siRNAs against RanBP2 or NUP214. (f) The effect of RanBP2 knockdown (induced with the RanBP2#3 siRNA) was rescued by expression
of the GFP-BICD2-NT-nesprin-3 fusion but not by GFP alone. (g) Cells were transfected with the indicated siRNAs against BICD2, and either untreated
or incubated with 4 mM STLC, an Eg5 inhibitor. Error bars represent SD; the number of experiments for each condition is shown in parentheses below
the graph; 20–30 cells were counted per experiment. Strong separation of the nucleus and the centrosomes is induced by dynein depletion. Mild
nuclear-centrosome separation is caused by overexpression of BICD2-CT or depletion of BICD2 or RanBP2, but not BICD1 or NUP214, which serve as
negative controls. A fusion of BICD2 N-terminus to the NE-targeting domain can compensate for the loss of RanBP2. The effect of BICD2 knockdown
on nuclear-centrosome positioning can be suppressed by inhibiting Eg5, suggesting that the MT sliding activity of this motor is responsible for
centrosome detachment in BICD2-depleted cells. (D) HeLa cells were transfected with GFP-BICD2-NT-nesprin-3 fusion, fixed with paraformaldehyde,
and stained for p150Glued. Note the recruitment of dynactin to the NE in the transfected cell.
doi:10.1371/journal.pbio.1000350.g006
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Pull-Downs, IP, Identification of BICD2-CT Binding
Partners by Mass Spectrometry, and Yeast Two-Hybrid
Analysis
Bio-GFP-BICD2-CT and BirA were transiently co-expressed in
HeLa cells; cells were lysed in a buffer containing 100 mM NaCl,
20 mM Tris-HCl, pH 7.5, 1% Triton X-100, and protease
inhibitors (Complete, Roche). Streptavidin pull-down assays, mass
spectrometry analysis, and IP from HEK293 cells overexpressing
different protein fusions were performed as described by [13]. For
the IP of endogenous proteins, HeLa cells were pelleted and lyzed in
a buffer containing 20 mM Tris pH 8.0, 150 mM KCl, 5% Triton
X-100, Protease inhibitors (Complete Roche) and phosphatase
inhibitors (Cocktail 1 and 2, Sigma). For the IP of endogenous
proteins from nocodazole-arrested cells, HeLa cells were treated
with 75 ng/mL nocodazole for 18 h, washed with PBS, lyzed with
digitonin in the buffer containing 20 mM HEPES pH 7.3, 110 mM
potassium acetate, 2 mM magnesium acetate, 1 mM EGTA, 1 mM
DTT and protease and phosphatase inhibitors; lysates were
centrifuged at 1000006g for 1 h. IP was carried out using standard
procedures. 6XHIS-tagged BICD2-CT (amino acids 630–820) was
generated in pET28a. GST fusions of RanBP2 fragments 3 and 4
(amino acids 2147–2287 and 2447–2887, accession number
NP_006258) were generated in pGEX-3X. Protein purification
and GST pull-down assays were carried out as described by [63].
Binding reactions were performed in 50 mM Tris-HCl, pH 7.5,
125 mM NaCl, 0.1% NP40, and 5 mM EDTA, using ,20 mg/ml
of HIS-BICD2-CT and ,70 mg/ml of GST fusions.
For yeast two-hybrid assays, different bait constructs were
prepared in pBHA (lexA fusion vector) and tested against various
BICD2 fragments cloned into pGAD10 (GAL4 activation domain
vector, Clontech) as described by [13].
Cell Culture and Transfection of Plasmids and siRNAs
HeLa, HEK293, and U2OS cells were cultured as described
previously [64,65]. PolyFect (Qiagen), Lipofectamine 2000
(Invitrogen), or FuGENE 6 (Roche) reagents were used for
plasmid transfection. Stable HeLa clones expressing fluorescent
proteins were selected using Fluorescence Activated Cell Sorting
and cultured in the presence of 0.4 mg/ml G418 (Roche).
Synthetic siRNAs were transfected into HeLa cells plated at
20% confluence using HiPerFect (Qiagen) at the final concentra-
tion 5 nM; cells were analyzed by 3 d after transfection. U2OS
cells were transfected with HiPerFect during plating at ,20%
confluence using 20 nM siRNAs; a second transfection with the
same siRNA concentration was performed 1 or 2 d later, and the
cells were analyzed 3 or 4 d after plating.
Antibodies, Immunofluorescent Staining, and Western
Blotting
We used affinity purified goat polyclonal antibodies against
RanBP2 and RanGAP1 [22,66]; rabbit polyclonal antibodies
against GFP (Abcam), BICD1 and BICD2 [8,11], HA tag, dynein
HC, KIF5B and RanGAP1 (Santa Cruz), NUP214 [41] (a gift of
Dr. R. Kehlenbach, University of Go¨ttingen, Germany), and
phosphorylated histone H3 (Ser 10) (Millipore); mouse monoclonal
antibodies against Rab6 (which recognizes Rab6A and Rab6A’, a
gift of A. Barnekow, University of Muenster, Germany), Arp1 (a
gift of Dr. T Schroer, Johns Hopkins University, USA),
nucleoporins (antibody 414, Covance), a-, b-, and c-tubulin
(Sigma), dynein IC (Chemicon and Santa Cruz), cyclin B1 (Santa
Cruz), p150Glued and p50 (BD Biosciences), pan-keratin (clone
C11, Sigma), and vimentin (Cymbus Biotechnology). For second-
ary antibodies we used Alexa 350, Alexa 488, and Alexa 594-
conjugated goat antibodies against rabbit, rat, and mouse IgG,
donkey antibodies against sheep IgG (Molecular Probes), AMCA-
labeled rat anti-mouse, FITC-labeled donkey anti-rabbit, and anti-
mouse antibodies (Jackson ImmunoResearch Laboratories). Actin
was stained with Alexa-594-conjugated phalloidin (Invitrogen).
Cell fixation and staining procedures were described previously
Figure 7. Dynein, kinesin-1, and BICD2 control the localization of AL in G2 phase. (A) HeLa cells were transfected with control, DHC#1,
p150Glued, or KIF5B#1 siRNAs, fixed with paraformaldehyde 3 d later, and stained for endogenous BICD2, RanBP2, and cyclin B1. In the overlays, BICD2
is shown in green and RanBP2 in red. The outline of the cyclin B1-positive cell is indicated. Note AL displacement to the cell periphery in cyclin B1-
positive cells depleted of dynein or dynactin, and the centripetal relocalization of AL in kinesin-1 (KIF5B) depleted cyclin B1-stained cell. (B) GFP-
RanGAP1 stable HeLa cell line was imaged with a 2 or 3 min time interval 2 d after transfection with the control, p150Glued, or KIF5B#1 siRNAs. 0 min
indicates the first frame after NEB (defined as the time when GFP-RanGAP1 enters the nucleus). Contrast is inverted. Arrows show the accumulation of
AL at the cell periphery or the cell center. Peripheral displacement of AL after dynein or dynactin knockdown occurred at 1 h630 min before mitotic
onset (mean 6 SD, measured in 6 and 10 cells, respectively); strong accumulation of AL near the nucleus in KIF5B depleted cells started at 3 h630 min
before NEB (mean 6 SD, measured in 18 cells). (C) AL localization after different siRNA co-transfections. Black bars represent the percentage of HeLa
cells showing a strong AL accumulation near the nucleus (like in the bottom panel in Figure 7A) and gray bars illustrate the percentage of HeLa cells
showing displacement of AL to the outmost cell periphery (like in the middle panels of Figure 7A). In each case, cells were transfected with a
combination of two siRNAs: control, KIF5B or dynein HC siRNAs (as indicated on top of the panel) in combination with the control siRNA or the siRNAs
against BICD1 and BICD2 (the cotransfected siRNA is indicated at the bottom), or the combination of KIF5B siRNAs and dynein HC siRNAs. Cells with AL
accumulation in the cell center or the cell periphery were scored in KIF5B or dynein knockdown cells, respectively; in a double KIF5B/dynein HC
knockdown, both types of cells were counted. Error bars represent SD.,30–100 cells were counted in three experiments. Cells with fully aggregated AL
represent a minority of the population (,20%) in control G2 cells but become predominant (,75%) after depletion of kinesin-1. This effect can be
suppressed by co-depletion of BICD2 or dynein HC, but not BICD1. Similarly, control cells never display peripheral AL localization, while ,40% of
dynein-depleted cyclin B1-positive cells show this phenotype, which can be suppressed by co-depletion of BICD2 or KIF5B, but not BICD1.
doi:10.1371/journal.pbio.1000350.g007
Figure 8. A model of the concerted action of BICD2, dynein,
and kinesin-1 in different phases of the cell cycle. In G1 and S
phase, BICD2, dynein, and kinesin-1 associate with Rab6 vesicles;
kinesin-1 activity predominates in this complex. In G2, BICD2 with the
associated motors accumulates at the NPCs, where the dynein-
mediated movement predominates, resulting in tight association of
the centrosome and nucleus.
doi:10.1371/journal.pbio.1000350.g008
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[8]. Briefly, we used the following fixations: 4% paraformaldehyde
in PBS (15 min at room temperature), 220uC methanol (10 min),
or 220uC methanol (10 min) immediately followed by 4%
paraformaldehyde in PBS (15 min at room temperature). For
pre-extraction of live cells we used the following buffer: 60 mM
PIPES, 25 mM HEPES, 10 mM EGTA, 0.5% Triton X-100,
4 mM MgSO4, and pH 7.5. Western blotting was performed as
described previously [64].
Electron Microscopy
For preembedding immunoperoxidase electron microscopy,
cells were fixed with 4% paraformaldehyde and stained with anti-
RanGAP1 using the same conditions as for immunofluorescence
with the exception that saponin (0.1%) was used as a detergent in
the preincubation step and no detergent was used in subsequent
steps. Biotinylated horse anti-goat (Vector) was used as the
secondary antibody, which was followed by incubation in avidin-
biotin-peroxidase complex (ABC, Vector Laboratories, USA) and
staining with diaminobenzidine (DAB, 0.05%) yielding a brown
reaction product. Subsequently cells were fixed in 1% osmium,
dehydrated, and embedded in Durcupan. Ultrathin (50–70 nm)
were contrasted with uranyl acetate and lead citrate and analyzed
in a Phillips CM100 electron microscope with a bottom mounted
TVIPS FastScan-F114 camera.
Fluorescence Microscopy and Image Analysis
Images of fixed cells with the exception of Figures 5A and 6B
were collected with a Leica DMRBE microscope equipped with
a PL Fluotar 1006 1.3 N.A. or 406 1.00–0.50 N.A. oil
objectives, FITC/EGFP filter 41012 (Chroma) and Texas Red
filter 41004 (Chroma), and an ORCA-ER-1394 CCD camera
(Hamamatsu). Images in Figures 5A and 6B were acquired on a
confocal Zeiss LSM510 META (CarlZeiss) with a Plan
Apochromat 636 1.4 N.A. objective. Z-planes were acquired
with 1 mm intervals. Images are maximum intensity projections
of all Z-planes.
Live cell imaging experiments with U2OS cells were performed
on a Zeiss Axiovert 200 M microscope equipped with a Plan-
Neofluar 406 1.3 N.A. oil objective in a permanently heated
chamber with 5% CO2. Images were acquired every 3–5 min
using a Photometrics Coolsnap HQ charged-coupled device
camera (Scientific, Tucson, AZ). Z-stacks were acquired with
2 mm intervals between Z-slices. Live cell imaging experiments
with HeLa cells were performed on the inverted microscope Nikon
Eclipse TE2000E (Nikon) with a CFI Plan Fluor 4061.30 N.A. oil
objective, equipped with CoolSNAP-HQ2 CCD camera (Roper
Scientific) controlled by MetaMorph 7.1 software (Molecular
Devices). For excitation we used HBO 103 W/2 Mercury Short
Arc Lamp (Osram) and Chroma ET-GFP (49002) or Chroma ET-
DsRed (49005) filter sets. Image analysis was performed by using
MetaMorph software (Universal Imaging, Downington, PA). Cells
were kept at 37uC during observation.
U2OS cells were microinjected in L-15 medium with dynein IC
70.1 (Sigma) or Myc (Covance) antibodies, diluted 1/10 from
suppliers stock, or with purified CC1 fragment of p150Glued (a gift
of Dr. S. King, University of Missouri–Kansas City, USA) using an
Eppendorf Micromanipulator 5171 coupled to a Transjector
5246, and cells were imaged as described above.
Images were prepared for publication using Adobe Photoshop.
The images of fixed cells were modified by adjustments of levels
and contrast. Live images were modified by adjustments of levels
and contrast and applying Unsharp Mask and Gaussian Blur
filters.
Supporting Information
Figure S1 Protein gel used for identification of bio-GFP-
BICD2-CT binding partners by mass spectrometry. To
identify binding partners of BICD2, streptavidin pull-down assays
were performed with extracts of HeLa cells expressing BirA alone
or together with bio-GFP-BICD2 full-length, N-terminus, or C
terminus. Proteins were separated on a 3%–8% Tris-acetate gel
and stained with Colloidal Blue Staining Kit (Invitrogen). Mass
spectrometry analysis of the proteins in the last lane is shown in
Table S1 (the first lane served as a control).
Found at: doi:10.1371/journal.pbio.1000350.s001 (0.28 MB TIF)
Figure S2 BICD2 associates with the NE in G2 phase in
a RanBP2-dependent manner in U2OS cells. (A) U2OS
cells were transfected with a control siRNA or a mixture of
RanBP2 siRNAs #1 and #2, fixed with cold methanol followed
by paraformaldehyde 3 d later, and stained for endogenous
BICD2, RanBP2, and cyclin B1. Note that BICD2 is strongly
recruited to the NE in cyclin B1 positive cells and that this
recruitment is blocked by RanBP2 depletion. (B) U2OS cells that
were either treated with 10 mM nocodazole or transfected with
control siRNAs or a mixture of RanBP2 siRNAs #1 and #2 were
stained as described for (A), and the percentage of cyclin B1-
positive cells showing BICD2 accumulation at the NE was
counted. In case of RanBP2 knockdown, only the cells in which
RanBP2-specific nuclear staining was reduced to background
levels were included in the quantification. Error bars represent SD;
,40–100 cells were counted in three experiments.
Found at: doi:10.1371/journal.pbio.1000350.s002 (0.66 MB TIF)
Figure S3 RanBP2 and RanGAP1-positive cytoplasmic
puncta are AL. (A,B) Control HeLa cells or cells either treated
for 1 h with 10 mM nocodazole were fixed with cold methanol and
stained with the antibodies to NPC components NUP214,
RanBP2, MAB414, and RanGAP1. (C) HeLa cells stably
expressing POM121-YFP(3) were fixed with paraformaldehyde
and stained with antibodies against RanBP2. Where indicated,
cells were treated for 1 h with 10 mM nocodazole. Note complete
co-localization of all NPC markers in the cytoplasmic puncta and
the enlargement of these puncta after nocodazole treatment. (D)
Transmission electron photomicrographs of HeLa cells treated
with 10 mM nocodazole for 1 h immunostained for RanGAP1
before plastic embedding using immunoperoxidase. Cells were
fixed with paraformaldehyde and stained with anti-RanGAP1
using an avidin-biotin-peroxidase complex procedure with diami-
nobenzidine as the chromogen yielding an electron dense
precipitate. Staining is selectively associated with either the
cytoplasmic face of NPCs in the NE, or with cytoplasmic
ensembles of nuclear pore-like structures also referred to as AL
(arrows). Nu, nucleus; m, mitochondrion; bars, 250 nm. This
result is fully consistent with previous descriptions of AL [49] and
shows that RanGAP1 is a good marker for these structures.
Found at: doi:10.1371/journal.pbio.1000350.s003 (3.88 MB TIF)
Figure S4 Protein depletion in HeLa and U2OS cells.
Western blots with the indicated antibodies were performed with
equal amounts of extracts of HeLa or U2OS cells 3 d after
transfection with the indicated siRNAs. Note that dynein, KIF5B,
BICD2, and NPC components can be depleted independently of
each other. The knockdown of dynein HC also causes depletion of
dynein IC, in agreement with published data [13].
Found at: doi:10.1371/journal.pbio.1000350.s004 (0.38 MB
DOC)
Figure S5 GFP fusions of BICD2 and BICD2 C terminus
co-localize with nuclear pores on the NE. HeLa cells were
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transfected with the indicated GFP fusions, treated with 10 mM
nocodazole, pre-extracted in a buffer with 0.5% Triton X-100,
fixed with paraformaldehyde, and stained for RanBP2. In the
overlays, BICD2 is shown in green and RanBP2 in red. Note
specific co-localization of the GFP fusions with the NPCs.
Found at: doi:10.1371/journal.pbio.1000350.s005 (0.98 MB TIF)
Figure S6 BICD2 is required for targeting dynein/
dynactin to the NE and AL. (A) HeLa cells were treated with
10 mM nocodazole for 1 h, fixed with cold methanol, and stained
for the indicated endogenous proteins. Dynactin is visualized with
antibody to Arp1 and p50/dynamitin. Colors used for the overlays
are indicated above the corresponding images. Note that in cells
where BICD2 associates with RanBP2-positive NE and AL,
dynactin subunits are also targeted to these structures. (B) HeLa
cells were transfected with a control siRNA (upper panel) or
BICD2#1 siRNA (bottom panel). Three days later, cells were
treated with 10 mM nocodazole for 5 h, fixed with cold methanol,
and stained for endogenous RanBP2, phospho-histone H3, and
dynactin (p150Glued). NE staining by dynactin antibodies is
indicated by an arrow. Colors used for the overlays are indicated
above the corresponding images. Note that dynactin is enriched at
the NE and annulate lamellae in control phospho-histone H3
positive cell, but not in BICD2-knockdown cell. (C) Percentage of
HeLa cells positive for phospho-histone H3 that show strong
accumulation of dynactin at the RanBP2-positive NE and AL in
control or BICD2-depleted cells 3 d after siRNA transfection.
Only the cells with clearly visible AL were included in the
quantification. Error bars represent SD; ,25–30 cells were
counted in two experiments.
Found at: doi:10.1371/journal.pbio.1000350.s006 (2.51 MB TIF)
Figure S7 Depletion of dynein and dynactin causes
separation of centrosomes and nuclei in prophase
U2OS and HeLa cells. (A) mCherry-a-tubulin stable U2OS
cell line was imaged with a 3 min time interval 2.5 d after
transfection with the indicated siRNA mixtures. Note that the
centrosomes separate completely from the NE envelope in a
dynein-depleted cell and that this effect is rescued by co-depletion
of KIF5B. 0 min indicates the first frame after NEB (defined as the
time when mCherry-a-tubulin entered the nucleus). (B) mCherry-
a-tubulin stable HeLa cell line was imaged with a 2 or 3 min time
interval 2.5 d after transfection with the control, p150Glued, or
DHC#2 siRNAs. 0 min indicates the first frame after NEB
(defined as the time when mCherry-a-tubulin entered the nucleus).
Note that the centrosomes separate completely from the NE
envelope in a dynein- or dynactin-depleted cell.
Found at: doi:10.1371/journal.pbio.1000350.s007 (1.50 MB TIF)
Figure S8 Microinjection of the recombinant coiled coil
fragment 1 (CC1) of p150Glued causes rapid separation of
centrosomes and the nucleus in prophase cells. U2OS
cells stably expressing mCherry-a-tubulin were microinjected with
recombinant CC1 at the needle concentration 0.85 mg/ml. Late
G2 cells were chosen based on the presence of separated
centrosomes. Time t = 0:00 indicates the time-point just prior to
injection.
Found at: doi:10.1371/journal.pbio.1000350.s008 (0.29 MB TIF)
Figure S9 Characterization of a HeLa cell line stably
expressing GFP-RanGAP1.Western blots prepared with equal
amounts of extracts of control HeLa cells or the stable GFP-
RanGAP1 HeLa cell line and incubated with antibodies against
GFP or RanGAP1. Note that the expression levels of the fusion
protein exceeded the endogenous RanGAP1 levels by approxi-
mately a factor of 4; however, the amount of SUMOylated
RanGAP1, which is likely to be RanBP2- and NPC-bound
[23,24], was not significantly altered compared to control cells; in
the stable cell line, this pool was predominantly represented by the
GFP-tagged RanGAP1.
Found at: doi:10.1371/journal.pbio.1000350.s009 (0.14 MB TIF)
Figure S10 The effect of MT motor depletion on AL
distribution. (A) HeLa cells were transfected with siRNAs
against KIF5B, fixed with cold methanol 3 d later, and stained for
RanBP2 and c-tubulin. Note that AL accumulate as a single
pericentrosomal dot in a cell with a single centrosome and around
both centrosomes after their separation. (B) HeLa cells were
transfected with KIF5B or DHC siRNAs, fixed with methanol,
and stained for endogenous NUP214, RanBP2, and with the
MAB414 antibody. (C) HeLa cells stably expressing POM121-
YFP(3) were transfected with KIF5B or DHC siRNAs, fixed with
paraformaldehyde, and stained with antibodies against RanBP2.
Note that all NPC markers show characteristic re-localization to
the centrosome or to the cell periphery, supporting the view that
these structures are indeed AL.
Found at: doi:10.1371/journal.pbio.1000350.s010 (1.65 MB TIF)
Figure S11 Behavior of AL in BICD2-depleted cells. (A)
HeLa cells were transfected with the indicated siRNAs, fixed 3 d
later with cold methanol followed by paraformaldehyde, and
stained for RanBP2 and cyclin B1. Note that AL are dispersed in
BICD2-depleted cyclin B1-positive cells. (B) Total area occupied
by AL was measured in ,25 cyclin B1-positive cells stained as
described for (A). Error bars represent SEM. The area is decreased
in KIF5B-depleted G2 cells because AL are strongly concentrated
in the pericentrosomal region and enlarged in BICD2-depleted
cells because AL are dispersed. (C) GFP-RanGAP1 stable HeLa
cell line was imaged with a 3 min time interval 2 d after
transfection with the BICD2#1 siRNA alone or in combination
with siRNAs against DHC#1 or KIF5B#1. 0 min indicates the
first frame after NEB. Contrast is inverted. Note that AL remain
dispersed and accumulated neither at the cell periphery nor the
cell center, even when dynein or KIF5B were co-depleted.
Found at: doi:10.1371/journal.pbio.1000350.s011 (0.93 MB TIF)
Figure S12 BICD2 depletion blocks re-localization of AL
caused by the knockdown of dynein or kinesin-1. HeLa
cells were transfected with the KIF5B#1 or DHC#1 siRNAs in
combination with the control or BICD2#1 siRNAs, fixed with
paraformaldehyde 3 d later, and stained for BICD2, RanBP2
(green in overlay), and cyclin B1 (red in overlay). Insets show
enlargement of cyclin B1-positive dynein-depleted cells. Accumu-
lations of AL at the two separated centrosomes in kinesin-1-
depleted cells and at the cell periphery in dynein-depleted cells are
indicated by arrows. Note that cells showing strong AL
displacement to the centrosome or the cell periphery cannot be
found in BICD2-codepleted cells.
Found at: doi:10.1371/journal.pbio.1000350.s012 (2.64 MB TIF)
Figure S13 Keratin and actin are not directly involved in
G2-specific displacement of nuclei and AL after dynein
and kinesin-1 depletion. (A) HeLa cells were transfected with
the indicated siRNAs, fixed with cold methanol 3 d later, and
stained for keratin, a-tubulin, and RanGAP1. Note that keratin
network looks similar in dynein HC and KIF5B-delpeted G2 cells
(which are identified by the characteristic position of the AL). This
is in agreement with published data indicating that keratin
distribution is not significantly affected by microtubule motors
[67]. (B) HeLa cells were transfected with the indicated siRNAs;
2 d later, cells were incubated overnight with 1 mm cytochalasin D
or left untreated. At 3 d post-transfection, cells were fixed with
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paraformaldehyde and stained with antibodies to a-tubulin and
RanGAP1, and with fluorescent phalloidin, to visualize the actin
network. Note that cytochalasin-induced disassembly of actin
fibers does not prevent separation of centrosomes (arrows) and
nuclei in a dynein-depleted cell or AL aggregation in KIF5B-
depleted cell.
Found at: doi:10.1371/journal.pbio.1000350.s013 (1.92 MB TIF)
Figure S14 Vimentin distribution is affected by knock-
down of dynein and kinesin-1 but does not correlate with
G2-specific displacement of nuclei and AL. (A,B) HeLa
cells were transfected with the indicated siRNAs, fixed with cold
methanol 3 d later, and stained for vimentin and RanGAP1. A cell
with the characteristic G2-specific aggregation of AL caused by
KIF5B depletion is indicated by an arrow. (B) shows a cell with the
characteristic G2-specific peripheral displacement of AL and the
nucleus caused by dynein HC depletion; note that vimentin
network is not re-localized to the cell corner together with the
nucleus. (C) Average fluorescence intensity of vimentin staining in
the perinuclear region normalized to the average fluorescence
intensity of the whole cell (expressed in %). Intensity of a circular
area (3 mm in diameter) was measured in ,20 cells; background
was subtracted. In case of dynein HC and KIF5B knockdowns,
two cell populations were analyzed: cells with randomly dispersed
AL (corresponding to G1 and S phase) and cells with strongly
aggregated (KIF5B depletion) or peripherally located (dynein HC
depletion) AL, which are in G2 phase. For the other conditions,
cell cycle stages were not discriminated. In agreement with
published data, the distribution of vimentin became more
concentrated in the center of the cell after KIF5B knockdown
and shifted to the cell periphery after dynein knockdown (A,C)
[67]. However, in contrast to the positioning of the nuclei and AL,
the distribution of vimentin was cell-cycle independent (C).
Moreover, in dynein-depleted cells that showed a strong displace-
ment of the nuclei into one cell corner, vimentin network remained
in the central part of the cell, indicating that vimentin redistribution
is not the underlying cause of the nuclear movement (B).
Found at: doi:10.1371/journal.pbio.1000350.s014 (1.73 MB
TIF)
Table S1 Identification of BICD2-CT binding partners
by mass spectrometry in HeLa cell extract. The table
shows the proteins identified with a significant Mascot score in the
pull-down with streptavidin beads from an extract of HeLa cells
co-expressing Bio-GFP-BICD2-CT (BICD2 amino acids 487–820)
and biotin ligase BirA. A pull-down from HeLa cells expressing
BirA alone was used as a control (only proteins that displayed
significantly higher Mascot score in the Bio-GFP-BICD2-CT lane
compared to the control lane are listed). The proteins were
separated on 3%–8% polyacrylamide gel (Figure S1); proteins
smaller than 50 kDa were not analyzed in this experiment. For
each identified protein, the list is filtered for duplicates and shows
only the hits with the highest score and most identified peptides.
Found at: doi:10.1371/journal.pbio.1000350.s015 (0.03 MB
DOC)
Video S1 Centrosome separation in control prophase
cells. Control HeLa cells expressing mCherry-a-tubulin were
imaged with a 3 min interval for 5 h and 30 min.
Found at: doi:10.1371/journal.pbio.1000350.s016 (2.74 MB
MOV)
Video S2 Centrosome separation in dynactin (p150Glued)-
depleted prophase cells. HeLa cells expressing mCherry-a-
tubulin were transfected with the siRNA against p150Glued and
imaged 2 d later with a 3 min interval for 5 h and 30 min.
Found at: doi:10.1371/journal.pbio.1000350.s017 (0.44 MB
MOV)
Video S3 Centrosome separation in dynein-depleted
prophase cells. HeLa cells expressing mCherry-a-tubulin were
transfected with the DHC#2 siRNA and imaged 2 d later with a
2 min interval for 4 h and 20 min.
Found at: doi:10.1371/journal.pbio.1000350.s018 (1.19 MB
MPG)
Video S4 Centrosome separation in control prophase
cells. Control U2OS cells expressing mCherry-a-tubulin were
imaged with a 5 min interval for 1 h and 50 min.
Found at: doi:10.1371/journal.pbio.1000350.s019 (0.73 MB
MOV)
Video S5 Centrosome separation in dynein-depleted
prophase cells. U2OS cells expressing mCherry-a-tubulin were
transfected with the DHC#1 siRNA and imaged 2.5 d later with a
3 min interval for 2 h and 30 min.
Found at: doi:10.1371/journal.pbio.1000350.s020 (0.69 MB
MOV)
Video S6 Peripheral displacement of the nucleus in
dynein-depleted cells prior to mitotic entry. HeLa cells
stably expressing GFP-RanGAP1 were transfected with the
DHC#2 siRNA and imaged 2 d later with a 3 min interval for
8 h and 30 min.
Found at: doi:10.1371/journal.pbio.1000350.s021 (1.17 MB
MOV)
Video S7 Peripheral displacement of the nuclei in
dynein-depleted cells prior to mitotic entry. HeLa cells
stably expressing GFP-RanGAP1 were transfected with the
DHC#2 siRNA and imaged 2 d later with a 3 min interval for
5 h and 30 min. Note abrupt separation of the nuclei.
Found at: doi:10.1371/journal.pbio.1000350.s022 (0.42 MB
MOV)
Video S8 Behavior of the AL in control cells. HeLa cells
stably expressing GFP-RanGAP1 were imaged with a 3 min
interval for 11 h (every second frame is shown).
Found at: doi:10.1371/journal.pbio.1000350.s023 (1.52 MB
MOV)
Video S9 Behavior of the AL in dynactin (p150Glued)-
depleted cells. HeLa cells stably expressing GFP-RanGAP1
were transfected with the siRNA against p150Glued and imaged 2 d
later with a 2 min interval for 6 h.
Found at: doi:10.1371/journal.pbio.1000350.s024 (4.43 MB
MOV)
Video S10 Behavior of the AL in KIF5B-depleted cells.
HeLa cells stably expressing GFP-RanGAP1 were transfected with
the KIF5B#1 siRNA and imaged 2 d later with a 3 min interval
for 6 h and 30 min.
Found at: doi:10.1371/journal.pbio.1000350.s025 (1.57 MB
MOV)
Video S11 Behavior of the AL in BICD2-depleted cells.
HeLa cells stably expressing GFP-RanGAP1 were transfected with
the BICD2#1 siRNA and imaged with a 3 min interval for 5 h
and 24 min.
Found at: doi:10.1371/journal.pbio.1000350.s026 (4.24 MB
MOV)
Video S12 Behavior of the AL in dynein/BICD2-deplet-
ed cells. HeLa cells stably expressing GFP-RanGAP1 were co-
transfected with the DHC#2 and BICD2#1 siRNAs and imaged
2 d later with a 3 min interval for 6 h and 6 min.
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Found at: doi:10.1371/journal.pbio.1000350.s027 (1.45 MB
MOV)
Video S13 Behavior of the AL in KIF5B/BICD2-depleted
cells. HeLa cells stably expressing GFP-RanGAP1 were co-
transfected with the KIF5B#1and BICD2#1 siRNAs and imaged
2 d later with a 3 min interval for 8 h.
Found at: doi:10.1371/journal.pbio.1000350.s028 (3.15 MB
MOV)
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